Close Menu

BGI

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BGI and Diagenode are collaborating to implement standard methods in epigenetics and next-generation sequencing sample preparation.

Officials from both organizations said this week that they are keen to use Exonhit's SpliceArray platform in new, sequencing-driven biomarker discovery projects.

Researchers using exome sequencing to study ADHD found rare mutations they think may be causing a patient's anemia, raising the question of how to handle unrelated findings in sequencing studies.

In a proof-of-concept paper, the BGI team demonstrated that it is possible to call structural variations from short-read sequencing data by using de novo assembly instead of alignment to a reference genome.

The project combines BGI's next-generation sequencing and Exonhit's SpliceArray technologies to expand the SpliceArray platform to an additional "strategic preclinical animal model species."

The project aims to sequence the genomes of 1,000 plant and animal that hold scientific and economic importance. It expects to have 200 species sequenced and assembled by the end of the year.

Under the deal, BGI will use Covaris' LE220 instrument and consumables as part of its library construction process for next-generation sequencing at several of its laboratories.

New Products: Jul 12, 2011

Premium

Ion Torrent's 316 chip, BGI's SOAP software

In an online presentation, Illumina emphasized the higher throughput and accuracy of its system compared to the Ion Torrent 314 chip. Life Technologies, meantime, contests some of Illumina's claims, touting the Ion Torrent platform as being a "truly disruptive technology."

BGI Europe is in the process of expanding its sales and marketing operations, is outfitting its new laboratory space, and is participating in several large sequencing studies, all ahead of an official opening.

Pages

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.